A Clinical Trial of TQC3721 Suspension for Inhalation

NCT05051930 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: TQC3721 suspension for inhalation
DRUG: TQC3721 suspension placebo for inhalation

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.